Streetbeat News

Stock Prices

ASAN

Asana's stock price is trading lower due to the company providing weaker than expected revenue guidance for fiscal year 2025.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:58 pm

MANU

Manchester United shares experienced an increase in trading following the announcement of their Q2 financial results, which surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:57 pm

HRTG

Heritage Insurance Holdings' shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:56 pm

MANU

Manchester United (NYSE:MANU) reported Q2 2024 adjusted EPS of $0.15, significantly beating the $(17.00) estimate. Sales reached $280.280M, surpassing the $173.000M estimate, marking a 42.83% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:55 pm

BODI

Beachbody's shares surged following the announcement of their Q4 revenue results, which exceeded expectations. Additionally, the company provided optimistic revenue guidance for Q1.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:55 pm

REFI

Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI) reported a 20% year-over-year growth in net income for 2023, with net interest income increasing by 17% and total expenses up by 39.4%. The company saw a sequential decrease in net income and distributable earnings in Q4 2023 due to increased management and incentive fees. Despite this, REFI's shares rose 2.20% in pre-market trading. The company expects to maintain a dividend payout ratio of 90% to 100% in 2024 and may issue a special dividend in Q4 2024 to meet taxable income distribution requirements.

Portfolio Pulse from Jelena Martinovic

March 12, 2024 | 12:55 pm

PFE

Pfizer Inc (NYSE:PFE) announced positive results from a Phase 3 study of Adcetris combined with lenalidomide and rituximab for treating diffuse large B-cell lymphoma (DLBCL), showing significant improvement in overall survival compared to a placebo combination. This marks the third Phase 3 study where an Adcetris combination has shown an overall survival benefit in lymphoma treatment. The results are notable for evaluating heavily pre-treated patients. Pfizer acquired Adcetris through its $43 billion acquisition of Seagen Inc. PFE shares saw a slight decrease of 0.09% in premarket trading.

Portfolio Pulse from Vandana Singh

March 12, 2024 | 12:55 pm

LMFA

Trading for LMFA was halted and then resumed at 8:55:00 AM ET, following an update on its status. This event indicates a significant occurrence that prompted the halt and subsequent resumption, which could be due to a variety of reasons such as financial disclosures, regulatory news, or other material events.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:55 pm

AAL

American Airlines Group's stock is trading lower following the company's announcement of an increase in its Q1 average fuel price guidance.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:52 pm

AAWH

Ascend Wellness (OTCQX:AAWH) reported a Q4 revenue of $140.2 million, a 0.8% decrease QoQ but a 25% increase YoY, with a net loss of $19.3 million. The company's full-year revenue reached $519 million, up 28% from the previous year, driven by retail and wholesale business expansion. Adjusted EBITDA for Q4 was $32.4 million, up 9.6% QoQ and 14.8% YoY. The company generated $16.7 million in cash from operations and $8.4 million in free cash flow for the quarter. For the full year, Ascend Wellness generated $54.5 million in cash from operations and $30.3 million in free cash flow. Shares closed 10.92% lower at $1.06 per share.

Portfolio Pulse from Nina Zdinjak

March 12, 2024 | 12:51 pm